Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8

The use of molecular-targeted drugs in the treatment of gastric cancer is increasing. However, the variety of molecular-targeted drugs in gastric cancer is still limited, and the development of new molecular-targeted therapies is required. The effect of combining sunitinib (SUN) with pterostilbene (...

Full description

Bibliographic Details
Main Authors: Yudai Hojo, Shingo Kishi, Shiori Mori, Rina Fujiwara-Tani, Takamitsu Sasaki, Kiyomu Fujii, Yukiko Nishiguchi, Chie Nakashima, Yi Luo, Hisashi Shinohara, Hiroki Kuniyasu
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/7/4002
_version_ 1797438888712601600
author Yudai Hojo
Shingo Kishi
Shiori Mori
Rina Fujiwara-Tani
Takamitsu Sasaki
Kiyomu Fujii
Yukiko Nishiguchi
Chie Nakashima
Yi Luo
Hisashi Shinohara
Hiroki Kuniyasu
author_facet Yudai Hojo
Shingo Kishi
Shiori Mori
Rina Fujiwara-Tani
Takamitsu Sasaki
Kiyomu Fujii
Yukiko Nishiguchi
Chie Nakashima
Yi Luo
Hisashi Shinohara
Hiroki Kuniyasu
author_sort Yudai Hojo
collection DOAJ
description The use of molecular-targeted drugs in the treatment of gastric cancer is increasing. However, the variety of molecular-targeted drugs in gastric cancer is still limited, and the development of new molecular-targeted therapies is required. The effect of combining sunitinib (SUN) with pterostilbene (PTE) on the human gastric cancer cell lines TMK1 and MKN74 was examined in in vitro and in vivo. Compared with SUN or PTE treatment alone, cotreatment induced pronounced suppression of cell proliferation, with a marked increase in oxidative stress. SUN was associated with a significant retention of mitochondrial Fe<sup>2+</sup>. SUN-treated cells decreased expression of PDZ domain-containing protein 8 (PDZD8). Knockdown of PDZD8 in both cells induced Fe<sup>2+</sup> retention, and siPDZD8+PTE markedly suppressed cell proliferation with suppressed oxidative phosphorylation, as did the combination of SUN+PTE. In a nude mouse tumor model, a pronounced antitumor effect was observed with SUN+PTE treatment compared to SUN alone. PDZD8 may be a newly discovered off-target for SUN, and that the combined use of PTE with SUN significantly promotes antitumor activity in gastric cancer cell lines. The combined use of SUN and PTE might be a new molecular-targeted therapy for gastric cancer.
first_indexed 2024-03-09T11:44:49Z
format Article
id doaj.art-c3ba461418544b7590c180663080c667
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T11:44:49Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-c3ba461418544b7590c180663080c6672023-11-30T23:25:14ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-04-01237400210.3390/ijms23074002Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8Yudai Hojo0Shingo Kishi1Shiori Mori2Rina Fujiwara-Tani3Takamitsu Sasaki4Kiyomu Fujii5Yukiko Nishiguchi6Chie Nakashima7Yi Luo8Hisashi Shinohara9Hiroki Kuniyasu10Department of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, JapanDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, JapanDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, JapanDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, JapanDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, JapanDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, JapanDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, JapanDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, JapanKey Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226001, ChinaDepartment of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya 663-8501, Hyogo, JapanDepartment of Molecular Pathology, Nara Medical University, 840 Shijo-cho, Kashihara 634-8521, Nara, JapanThe use of molecular-targeted drugs in the treatment of gastric cancer is increasing. However, the variety of molecular-targeted drugs in gastric cancer is still limited, and the development of new molecular-targeted therapies is required. The effect of combining sunitinib (SUN) with pterostilbene (PTE) on the human gastric cancer cell lines TMK1 and MKN74 was examined in in vitro and in vivo. Compared with SUN or PTE treatment alone, cotreatment induced pronounced suppression of cell proliferation, with a marked increase in oxidative stress. SUN was associated with a significant retention of mitochondrial Fe<sup>2+</sup>. SUN-treated cells decreased expression of PDZ domain-containing protein 8 (PDZD8). Knockdown of PDZD8 in both cells induced Fe<sup>2+</sup> retention, and siPDZD8+PTE markedly suppressed cell proliferation with suppressed oxidative phosphorylation, as did the combination of SUN+PTE. In a nude mouse tumor model, a pronounced antitumor effect was observed with SUN+PTE treatment compared to SUN alone. PDZD8 may be a newly discovered off-target for SUN, and that the combined use of PTE with SUN significantly promotes antitumor activity in gastric cancer cell lines. The combined use of SUN and PTE might be a new molecular-targeted therapy for gastric cancer.https://www.mdpi.com/1422-0067/23/7/4002sunitinibpterostilbenePDZD8mitochondriaoxidative stress
spellingShingle Yudai Hojo
Shingo Kishi
Shiori Mori
Rina Fujiwara-Tani
Takamitsu Sasaki
Kiyomu Fujii
Yukiko Nishiguchi
Chie Nakashima
Yi Luo
Hisashi Shinohara
Hiroki Kuniyasu
Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8
International Journal of Molecular Sciences
sunitinib
pterostilbene
PDZD8
mitochondria
oxidative stress
title Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8
title_full Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8
title_fullStr Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8
title_full_unstemmed Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8
title_short Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8
title_sort sunitinib and pterostilbene combination treatment exerts antitumor effects in gastric cancer via suppression of pdzd8
topic sunitinib
pterostilbene
PDZD8
mitochondria
oxidative stress
url https://www.mdpi.com/1422-0067/23/7/4002
work_keys_str_mv AT yudaihojo sunitinibandpterostilbenecombinationtreatmentexertsantitumoreffectsingastriccancerviasuppressionofpdzd8
AT shingokishi sunitinibandpterostilbenecombinationtreatmentexertsantitumoreffectsingastriccancerviasuppressionofpdzd8
AT shiorimori sunitinibandpterostilbenecombinationtreatmentexertsantitumoreffectsingastriccancerviasuppressionofpdzd8
AT rinafujiwaratani sunitinibandpterostilbenecombinationtreatmentexertsantitumoreffectsingastriccancerviasuppressionofpdzd8
AT takamitsusasaki sunitinibandpterostilbenecombinationtreatmentexertsantitumoreffectsingastriccancerviasuppressionofpdzd8
AT kiyomufujii sunitinibandpterostilbenecombinationtreatmentexertsantitumoreffectsingastriccancerviasuppressionofpdzd8
AT yukikonishiguchi sunitinibandpterostilbenecombinationtreatmentexertsantitumoreffectsingastriccancerviasuppressionofpdzd8
AT chienakashima sunitinibandpterostilbenecombinationtreatmentexertsantitumoreffectsingastriccancerviasuppressionofpdzd8
AT yiluo sunitinibandpterostilbenecombinationtreatmentexertsantitumoreffectsingastriccancerviasuppressionofpdzd8
AT hisashishinohara sunitinibandpterostilbenecombinationtreatmentexertsantitumoreffectsingastriccancerviasuppressionofpdzd8
AT hirokikuniyasu sunitinibandpterostilbenecombinationtreatmentexertsantitumoreffectsingastriccancerviasuppressionofpdzd8